Funder
National Cancer Institute
Funk Out Cancer
Publisher
Springer Science and Business Media LLC
Reference87 articles.
1. Sokol, Caroline L., Zamaneh Mikhak, and Andrew D. Luster. “Chemokines.” In Middleton’s allergy: principles and practice, 9th ed., 95–109.e1. Philadelphia, PA, 2020. https://www-clinicalkey-com.ezproxy.library.wisc.edu/#!/content/book/3-s2.0-B9780323544245000071?scrollTo=%23hl0000619. Accessed 2 Feb 2021.
2. Kaiko GE, Horvat JC, Beagley KW, Hansbro PM. “Immunological decision-making: how does the immune system decide to mount a helper T-cell response?” Immunology. 2008;123(3):326–38. https://doi.org/10.1111/j.1365-2567.2007.02719.x.
3. • Greene S, Robbins Y, Mydlarz W, Huynh A, Schmitt N, Friedman J, Horn L, Palena C, et al. Inhibition of MDSC trafficking with SX-682, a CXCR1/2 inhibitor, enhances NK-cell immunotherapy in head and neck cancer models. Clin Cancer Res. March 2020;26(6):1420–31. https://doi.org/10.1158/1078-0432.CCR-19-2625.. (NK cell-based immunotherapies are an exciting treatment prospect for patients. This study identifies CXCR1/2 as a target for enhancing these therapies.)
4. Wang J, Hu W, Wang K, Yu J, Luo B, Luo G, Wang W, Wang H, et al. Repertaxin, an inhibitor of the chemokine receptors CXCR1 and CXCR2, inhibits malignant behavior of human gastric cancer MKN45 cells in vitro and in vivo and enhances efficacy of 5-fluorouracil. Int J Oncol. February 2016;48:1341–52. https://doi.org/10.3892/ijo.2016.3371.
5. Lazaar AL, Miller BE, Tabberer M, Yonchuk J, Leidy N, Ambery C, Bloomer J, et al. Effect of the CXCR2 antagonist danirixin on symptoms and health status in COPD. Eur Respir J. 2018;52:1801020. https://doi.org/10.1183/13993003.01020-2018.
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献